[News Release: FDA Advisory Committe Recommends Approval of Retrovir (AZT) for HIV-Positive Pregnant Wome and Infants]
Description: A news release from Burrough Wellcome Co. about their brand of zidovudine (AZT), Retrovir, being approved by the FDA to reduce the risk of HIV transmission from pregnant mothers to their infants.
Creator: Burroughs Wellcome Co.
Item Type: Refine your search to only Text
Partner: UNT Libraries Special Collections